Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Nutting

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
The British Journal of Radiology|April 1, 2009
Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancerC H Clark, E A Miles, M T Guerrero Urbano, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2009
Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinomaP J Ross, E M Teoh, R P A'hern, et al.
Oral Oncology|March 15, 2013
Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysisA C Wilkins, N Rosenfelder, U Schick, et al.
British Journal of Cancer|February 3, 2005
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effectsD P Dearnaley, E Hall, D Lawrence, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|June 15, 2007
Postlaryngectomy vocal rehabilitation: assessment using a validated questionnaire in 51 patientsR Kazi, A Singh, J De Cordova, et al.
Postgraduate Medical Journal|April 17, 2003
Raynaud's phenomenon after radical radiotherapy for tumours of the head and neckC B Westbury, K J Harrington, P Rhys-Evans, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelinesM T Guerrero Urbano, C H Clark, C Kong, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 21, 2016
Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated RadiotherapyA B Miah, S L Gulliford, J Morden, et al.
Oral Oncology|November 23, 2013
Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: a survey of centres participating in a national randomised controlled trialD M Gujral, D Piercy, J P Morden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2018
Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation studyK P Rooney, A B Miah, S A Bhide, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
The British Journal of Radiology|April 1, 2009
Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancerC H Clark, E A Miles, M T Guerrero Urbano, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 10, 2009
Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinomaP J Ross, E M Teoh, R P A'hern, et al.
Oral Oncology|March 15, 2013
Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysisA C Wilkins, N Rosenfelder, U Schick, et al.
British Journal of Cancer|February 3, 2005
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effectsD P Dearnaley, E Hall, D Lawrence, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|June 15, 2007
Postlaryngectomy vocal rehabilitation: assessment using a validated questionnaire in 51 patientsR Kazi, A Singh, J De Cordova, et al.
Postgraduate Medical Journal|April 17, 2003
Raynaud's phenomenon after radical radiotherapy for tumours of the head and neckC B Westbury, K J Harrington, P Rhys-Evans, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelinesM T Guerrero Urbano, C H Clark, C Kong, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 21, 2016
Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated RadiotherapyA B Miah, S L Gulliford, J Morden, et al.
Oral Oncology|November 23, 2013
Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: a survey of centres participating in a national randomised controlled trialD M Gujral, D Piercy, J P Morden, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 12, 2018
Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation studyK P Rooney, A B Miah, S A Bhide, et al.
Pageof 9